In 2007 was created Capital Community Angel Investors, which is appeared as Corporate Investor. The leading representative office of defined Corporate Investor is situated in the East Lansing. The company was established in North America in United States.
The fund has no exact preference in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Among the various public portfolio startups of the fund, we may underline Avegant, Vestaron Corporation, HistoSonics Among the most popular fund investment industries, there are Energy, Marketing. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.
The usual things for fund are deals in the range of 1 - 5 millions dollars. Opposing the other organizations, this Capital Community Angel Investors works on 22 percentage points less the average amount of lead investments. The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2014. Despite it in 2019 the fund had an activity. The top amount of exits for fund were in 2017.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Capital Community Angel Investors, startups are often financed by Ann Arbor SPARK, Venture Investors, Michigan Angel Fund. The meaningful sponsors for the fund in investment in the same round are Michigan Angel Fund, Wakestream Ventures, RSL Venture Partners. In the next rounds fund is usually obtained by Pangaea Ventures, Open Prairie, Cultivian Sandbox Ventures.
Related Funds
Funds with similar focus
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
ONL Therapeutics | $15M | 08 Mar 2023 | Ann Arbor, Michigan, United States | ||
ONL Therapeutics | $46M | 22 Dec 2020 | Ann Arbor, Michigan, United States | ||
ONL Therapeutics | $4M | 17 May 2017 | Ann Arbor, Michigan, United States | ||
Avegant | $9M | 04 Nov 2014 | California, United States | ||
Vestaron | $10M | 21 Aug 2014 | Durham, North Carolina, United States | ||
ONL Therapeutics | $501K | 02 Jul 2014 | Ann Arbor, Michigan, United States | ||
VNN | $3M | 17 Feb 2014 | Grand Rapids, Michigan, United States | ||
Biophotonic Solutions | $1M | 01 Oct 2013 | Michigan, United States | ||
Vestaron | $10M | 08 May 2012 | Durham, North Carolina, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
ONL Therapeutics | $15M | 08 Mar 2023 | Ann Arbor, Michigan, United States | ||
ONL Therapeutics | $46M | 22 Dec 2020 | Ann Arbor, Michigan, United States | ||
ONL Therapeutics | $4M | 17 May 2017 | Ann Arbor, Michigan, United States | ||
Avegant | $9M | 04 Nov 2014 | California, United States | ||
Vestaron | $10M | 21 Aug 2014 | Durham, North Carolina, United States | ||
ONL Therapeutics | $501K | 02 Jul 2014 | Ann Arbor, Michigan, United States | ||
VNN | $3M | 17 Feb 2014 | Grand Rapids, Michigan, United States | ||
Biophotonic Solutions | $1M | 01 Oct 2013 | Michigan, United States | ||
Vestaron | $10M | 08 May 2012 | Durham, North Carolina, United States |